Y chromosome azoospermia factor region microdeletions are not associated with idiopathic recurrent spontaneous abortion in a Slovenian population: association study and literature review by Pereza, Nina et al.
ORIGINAL ARTICLES: EARLY PREGNANCYY chromosome azoospermia factor
region microdeletions are not
associated with idiopathic recurrent
spontaneous abortion in a Slovenian
population: association study and
literature review
Nina Pereza, M.D.,a Ksenija Crnjar, M.D.,a Alena Buretic-Tomljanovic, Ph.D.,a Marija Volk, M.D.,b
Miljenko Kapovic, M.D., Ph.D.,a Borut Peterlin, M.D., Ph.D.,b and Sasa Ostojic, M.D., Ph.D.a
a Department of Biology and Medical Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; and b Clinical
Institute of Medical Genetics, Department of Gynecology and Obstetrics, University Medical Centre, Ljubljana, SloveniaObjective: To investigate the potential association of Y chromosome microdeletions with idiopathic recurrent spontaneous abortion
(IRSA) in a Slovenian population and compare our results with those of previously published studies in different populations, with
the intention of clarifying the potential impact of Y chromosome microdeletions on IRSA.
Design: Case–control and association study.
Setting: Departments of gynecology and obstetrics and university-based research laboratory.
Patient(s): Male partners of 148 couples with at least three spontaneous pregnancy losses of unknown etiology, and 148 fertile men.
Intervention(s): Multiplex polymerase chain reactions.
Main Outcome Measure(s): Azoospermia factor (AZF) regions were tested for Y chromosome microdeletions according to European
Academy of Andrology/European Molecular Genetics Quality Network guidelines. The PubMed database was searched to retrieve
articles linking Y chromosome microdeletions and susceptibility to IRSA.
Result(s): None of the IRSA or control men had microdeletions in the AZFa, AZFb, or AZFc regions. A total of nine previous studies
examined the relationship between Y chromosome microdeletions and IRSA, yielding contradictory results, which we discuss in detail.Use your smartphoneConclusion(s): On the basis of our comparisons, it is unlikely that Y chromosome microdele-
tions contribute to IRSA and are therefore currently not recommended for the routine evaluation
of IRSA couples. (Fertil Steril 2013;99:1663–7. 2013 by American Society for Reproductive
Medicine.)
Key Words: Male infertility, microdeletions, miscarriage, pregnancy, spermatogenesis
Discuss: You can discuss this article with its authors and with other ASRM members at http://
fertstertforum.com/perezan-miscarriage-microdeletions-spermatogenesis/to scan this QR code
and connect to the
discussion forum for
this article now.*
* Download a free QR code scanner by searching for “QR
scanner” in your smartphone’s app store or app marketplace.Received November 26, 2012; accepted January 7, 2013; published online February 11, 2013.
N.P. has nothing to disclose. K.C. has nothing to disclose. A.B.-T. has nothing to disclose.M.V. has noth-
ing to disclose. M.K. has nothing to disclose. B.P. has nothing to disclose. S.O. has nothing to
disclose.
This research is part of the project ‘‘Genetic factors in etiology of recurrent spontaneous abortion’’
(no. 062-0000000-3548), supported by the Ministry of Science, Education and Sports, Zagreb,
Croatia, as well as Slovenian Research Agency grant P3-0326 (Gynecology and reproduction:
Genomics and stem cells). The results of this study are part of the Human Miscarriage Genetic
Network (HuMGeN) international project started by research groups from Slovenia and Croatia.
Reprint requests: Sasa Ostojic, M.D., Ph.D., Department of Biology and Medical Genetics, Faculty of
Medicine, University of Rijeka, B. Branchetta 20, 51000 Rijeka, Croatia (E-mail: sasa.ostojic@
medri.uniri.hr).
Fertility and Sterility® Vol. 99, No. 6, May 2013 0015-0282/$36.00
Copyright ©2013 American Society for Reproductive Medicine, Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.fertnstert.2013.01.101
VOL. 99 NO. 6 / MAY 2013R ecurrent spontaneous abortion(RSA), deﬁned as three or morespontaneous pregnancy losses
with the same partner before the 24th
week of gestation, represents a separate
entity in human infertility, affecting
3%–5% of couples trying to conceive
(1, 2). Although RSA comprises a large
group of heterogeneous conditions
of genetic and nongenetic etiology,
the cause cannot be identiﬁed
in approximately 50% of couples1663
ORIGINAL ARTICLE: EARLY PREGNANCY(idiopathic RSA; IRSA). The known causes are usually
classiﬁed as either fetal or maternal, whereas the potential
contribution of male factors, such as sperm quality, paternal
age, and gene mutations, remains largely unexplored (3, 4).
As a result, clinical investigation of RSA couples focuses
mostly on the evaluation of the mother and conceptus,
whereas both parents are included only in the cytogenetic
analysis (5).
Several studies have indicated that the sperm genome and
epigenome provide speciﬁc molecular regulatory factors
required for fertilization and proper embryonic development
(6, 7). Consequently, it has been suggested that
abnormalities of the sperm genome, including chromosome
aberrations, chromatin fragmentation, oxidative stress, and
Y chromosome microdeletions, might be the underlying
cause in some cases of IRSA (8–10).
Y chromosome microdeletions are a well-established
cause of spermatogenetic impairment and male infertility
(11, 12). Even though the actual prevalence of clinically
relevant microdeletions is still unclear, severely
oligozoospermic or azoospermic men have the highest risk
of carrying a Y chromosome microdeletion (4). Various
studies have reported signiﬁcant differences in the
prevalence of microdeletions in infertile men, ranging from
5% to 35%, which can be attributed to different patient
selection criteria and laboratory techniques used to detect
the microdeletions (13–15). Y chromosome microdeletions
commonly occur in the band q11.23, at the azoospermia
factor (AZF) locus, which is further subdivided into AZFa,
AZFb, and AZFc regions. These microdeletions are
classiﬁed as one of six classic types: AZFa, AZFb, AZFc,
AZFbc, AZFabc, and partial AZFc, all of which result in
different degrees of spermatogenetic failure (12, 16);
however, the function of genes located in the AZF region
and the exact genotype–phenotype correlation are
unknown.
Considering that the initiation and maintenance of
a viable pregnancy depends on the integrity of the paternal
genome, several studies attempted to evaluate the association
between Y chromosome microdeletions and IRSA but yielded
contradictory results (8, 10, 17–23). To investigate the
potential association of Y chromosome microdeletions
with IRSA in a Slovenian population, we performed
a case–control study in male partners of IRSA women.
Furthermore, we compared our results with those of
previously published studies in different populations with
the intention of clarifying the potential impact of
Y chromosome microdeletions on IRSA.MATERIALS AND METHODS
Patients and Control Subjects
All subject samples were collected at the Institute of Medical
Genetics, Department of Obstetrics and Gynecology, Univer-
sity Medical Centre, Ljubljana, Slovenia from 2005 to 2011,
according to a protocol approved by the Slovenian National
Ethics Committee. Written informed consent to participate
in this study was obtained from all individuals. This study1664was approved by the Slovenian National Ethics Committee.
All subjects included in the study were Slovenian.
The patient group consisted of 148 men of 148 couples
with a history of three or more spontaneous abortions of
unknown etiology before the 24th week of gestation. These
couples were previously recruited for case–control genetic
association studies investigating the role of different
genetic polymorphisms in the etiology of IRSA and were
selected using strict criteria. The inclusion criteria for
women were as follows: no endocrine, autoimmune,
metabolic, or other systemic disorders and no previous
venous or arterial thrombosis or uterine anatomic
abnormalities. Additionally, both partners had normal
karyotypes. Characteristics of IRSA couples have been
described in detail previously (24, 25).
The control group consisted of 148 unrelated, healthy
Caucasian men who had at least two children and whose
partners had never experienced spontaneous abortions or
any other pregnancy complications.DNA Extraction
Peripheral venous blood samples (3–5 mL) were collected
from IRSA couples and controls, and genomic DNA was
extracted from peripheral blood leukocytes by standard
procedure using a commercially available kit (FlexiGene
Kit; Qiagen), according to the manufacturer's instructions.
Extracted DNA was stored at 20C.Molecular Analysis
The AZFa, AZFb, and AZFc regions were tested for Y chromo-
some microdeletions using multiplex polymerase chain
reaction systems according to recommendations made by
the European Academy of Andrology/European Molecular
Genetics Quality Network (EAA/EMQN) guidelines provided
for diagnostic laboratories (26). Two multiplex reactions
(A and B) were used for the analysis of the three AZF regions
on the Y chromosome. Each multiplex contained ﬁve
sequence-tagged sites (STS) spanning AZFa–c regions:
sY86, sY127, and sY254 for multiplex A; sY84, sY134, and
sY255 for multiplex B; and two control fragments used in
both multiplexes—the sex-determining region of the Y
chromosome (SRY/sY14) and zinc ﬁnger protein of Y
chromosome/zinc ﬁnger protein of X chromosome (ZFY/
ZFX). The ZFY/ZFX was used as an internal control, whereas
the SRY gene was examined to conﬁrm the sex of the donor.
According to the EAA/EMQN guidelines, this primer set
enables the detection of almost all clinically relevant
deletions and >95% of all AZFa, AZFb, and AZFc deletions
reported in the literature (26).
All reactions were performed in a thermal cycler (Master-
cycle Personal; Eppendorf). Ampliﬁcation conditions started
with an initial activation step of 5 minutes (94C), followed
by 35 cycles of 60 seconds denaturation (94C), 60 seconds
annealing (58C), and 60 seconds elongation (72C), plus
a ﬁnal elongation step of 10 minutes (72C).
The polymerase chain reaction products were separated
by electrophoresis on a 2% agarose gel stained with ethidiumVOL. 99 NO. 6 / MAY 2013
TABLE 1
Comparison of the present study and previously published studies investigating the association of Y chromosome microdeletions and IRSA.
Reference
Patients
(n)
Controls
(n) STS Spermiogram
No. (%) of patients with
microdeletions Population
Present study 148 148 AZFa: sY84, sY86
AZFb: sY127, sY134
AZFc: sY254, sY255
þ SRY, ZFY
NA 0 Slovenian
Dewan et al. (17) 17 18 AZFb: DYS220 (sY129)
AZFc: DYF85S1 (sY150), DYF86S1
(sY152)
þ DYS262 (sY67)
NA 14 (82)a American
Karaer et al. (19) 43 43 AZFb: DYS220 (sY129)
AZFc: DYS235 (sY150), DYS236
(sY152), DYS237 (sY153)
32 NS
1 OS
6 TAS
7 (16):
5 in DYS220
2 in DYS220 þ DYS237
Turkish
Lu et al. (20) 51 NA AZFa: sY84, sY86
AZFb: sY127, sY134
AZFc: sY254, sY255
þ SRY, ZFY
NA 0 Chinese
Kaare et al. (10) 40 NA AZFa: sY81, sY82, sY84, Y6HP35pr
(DYS274, sY85), sY86
AZFb: Y6D14pr (DYS205, sY113),
sY117, Y6PHc54pr (Y6H54),
sY127, sY134, sY144, sY145,
DYS220 (sY129)
AZFc: Fr15-lipr, Y6HP52pr
(DYS239, sY156), sY147, sY149,
sY254, sY255, sY277, sY283,
sY157, sY158, sY159, DYF85S1
(sY150), DFY86S1 (sY152)
þ SRY, DYS262 (sY67), sY160,
sY88, sY182, sY151, sY94,
sY95, sY97, sY102, sY105
NA 0 Finnish
Wettasinghe
et al. (23)
76 120 AZFa: sY84, sY86
AZFb: sY127, sY134
AZFc: sY254, sY255
Other: sY1191, sY1291, sY1201,
sY1206, sY1161
þ SRY, ZFY
41 NS
5 OS
2 AS
2 AS/OS
0 Sinhalese
Bellver et al. (8) 30 30 AZFa: sY81, sY84s, sY86
AZFb: sY182, sY121, sYPR3,
sY124, sY127, sY128, sY130,
sY133, sY134
AZFc: sY145, sY152, sY242,
sY208, sY254, sY255
þ sY157
NS 0 Spanish
Venkatesh et al. (22) 48 20 AZFa: sY84, sY86
AZFb: sY127, sY134
AZFc: sY254, sY255
þ SRY, ZFY
16 OS 0 Indian
Ghorbian et al. (18) 100 100 AZFa: sY84, sY86
AZFb: sY127, sY134
AZFc: sY254, sY255, sY150, sY152
þ SRY
NA 0 Iranian
Pi~na-Aguilar et al. (21) 71 66 AZFa: sY84, sY86
AZFb: sY127, sY134, DYS220
(sY129)
AZFc: sY254, sY255, sY150,
sY152, DYF85S1 (sY150),
DYF86S1 (sY152)
þ SRY, DYS262 (sY67), DYF87S1
(sY153)
NA 0 Mexican
Note: NA ¼ not available; NS ¼ normozoospermia; OS ¼ oligozoospermia; TAS ¼ teratoasthenozoospermia; AS ¼ asthenozoospermia.
a Results of the analysis for each patient are not provided in the article.
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from a man with an already conﬁrmed deletion (AZFb) was
used as a positive control, whereas negative control DNA
was obtained from a woman.VOL. 99 NO. 6 / MAY 2013Literature Search Strategy
The PubMed database was searched to retrieve articles linking
Y chromosome microdeletions and susceptibility to IRSA
published up to September 2012 and without language1665
ORIGINAL ARTICLE: EARLY PREGNANCYrestrictions. The following key words were used: ‘‘recurrent
spontaneous abortion,’’ ‘‘recurrent miscarriage,’’ ‘‘recurrent
pregnancy loss,’’ ‘‘Y chromosome microdeletions,’’ and
‘‘AZF microdeletions.’’
RESULTS
Molecular Analysis of Y Chromosome
Microdeletions
All eight STS loci were detected in all subjects, thereby
conﬁrming that none of the 148 patients and 148 controls
had microdeletions in the AZFa, AZFb, or AZFc regions.Literature Search Strategy
A total of nine publications evaluating the potential role of Y
chromosome microdeletions in IRSA have been retrieved.
These studies differ to a large extent, using different method-
ologies and yielding contradictory results (Table 1). Couples
with three or more spontaneous abortions were included in
all studies, with the exception of the one by Venkatesh
et al. (22), in which patients with two or more spontaneous
abortions were investigated. Studies in which patient
selection criteria were not described were not included in
this analysis (27). A positive correlation between Y
chromosome microdeletions and IRSA was reported in two
of these studies, whereas the other seven, as well as the
present study, failed to conﬁrm these results.
DISCUSSION
In the present study we investigated the potential association
between Y chromosome microdeletions and IRSA, studying
the largest number of male partners of IRSA women yet
published. We used the six STS loci recommended by the
EAA/EMQN guidelines in the analysis and found that none
of the IRSA or control men had microdeletions in the AZFa,
AZFb, or AZFc regions, indicating that these do not contribute
to the etiology of IRSA in a Slovenian population.
In addition, we searched the available literature and
found that nine previous studies examined the relationship
between Y chromosome microdeletions and IRSA. A positive
correlation between Y chromosome microdeletions and IRSA
was found in two of these studies, both of which were subject
to much discussion owing to the disputable patient selection
criteria and the methodology used for detection of microdele-
tions, which did not conform to the EAA/EMQN guidelines.
In the ﬁrst study, Dewan et al. (17) found Y chromosome
microdeletions set in the AZFb (DYS220/sY129) and/or AZFc
(DYF85S1/sY150 and DYF86S1/sY152) regions in 14 of 17
IRSA men (82%). Another STS found to be deleted in IRSA
men, the DYS262/sY67, is located outside the AZF region.
These results indicate that IRSA men have multiple deleted
regions on Y chromosome, which is highly unlikely in
a normal male (23). Although Dewan et al. (17) reported to
have used four STSs—one located in the AZFb region
(DYS220) and three in the AZFd region (sY150, DYS236/
sY152, and DYS237/sY153)—there is no conﬁrmed evidence
that the AZFd zone exists. Therefore, all STSs referred to as
AZFd in this study correspond to the AZFc zone (26, 28, 29).1666Additionally, the authors did not use the ﬁve Yq STS
markers recommended by Repping et al. (30) for further
delineation of the AZFc deletions. Although the AZFc
deletions are relatively frequent, the contribution of
different partial AZFc deletions to male infertility varies and
requires further genotype–phenotype correlations before
indications can be given for their use in clinical routine (30,
31). Another weakness of the study by Dewan et al. (17) is
the small number of patients who were selected from
a tertiary referral center and were likely to have had failed
evaluations and treatments before referral.
In the second study, Karaer et al. (19) reported that Y
chromosome microdeletions were found in 7 of 43 men
(16%). All of these men hadmicrodeletions in the AZFb region
(DYS220/sY129), whereas two men had a microdeletion in
both the AZFb (DYS220/sY129) and AZFc (DYS237/sY153)
regions. Pi~na-Aguilar et al. (29) pointed out that both of these
deletions are polymorphic traits that cannot be considered
true microdeletions but rather polymorphisms or methodo-
logic mistakes not fulﬁlling the criteria for an accurate
diagnosis (26, 28). Moreover, all of the IRSA men carrying
microdeletions in this study had normal spermiograms,
which is not typical of AZFb microdeletions.
In the remaining seven studies (8, 10, 18, 20–23) as well as
in our study, no correlation was found between Y
chromosome microdeletions and IRSA. Y chromosome
microdeletions were evaluated according to the EAA/EMQN
guidelines in all of these studies, and Bellver et al. (8),
Ghorbian et al. (18), Kaare et al. (10), Pi~na-Aguilar et al.
(21), and Wettasinghe et al. (23) used several additional
STSs for the screening of AZFb and AZFc subdeletions.
Although none of these studies conﬁrmed the presence of Y
chromosome microdeletions in peripheral blood
lymphocytes, this does not exclude the possibility of sperm
chromosome abnormalities arising through de novo
mutations.
In conclusion, on the basis of our and previously reported
results, it is unlikely that Y chromosome microdeletions are
associated with IRSA and are therefore not recommended
for the routine evaluation of IRSA couples.REFERENCES
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